According to the latest report by IMARC Group “Nerve Repair and Regeneration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global nerve repair and regeneration market size reached US$ 6.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2027, exhibiting a growth rate (CAGR) of 11.4% during 2022-2027.
Nerve repair and regeneration (NRaR) is performed to support the replacement of injured nervous tissue caused by trauma or neurodegenerative diseases. It promotes the regrowth of new neurons, myelin, axon, synapses, and glial cells to restore normal nerve functionalities. NRaR employs biomaterials, along with neurostimulation and neuromodulation devices, for conducting nerve grafting, direct Neurotherapy, stem cell therapy, transcranial magnetic, and sacral nerve stimulation. As a result, they are extensively applied in cell relocation studies, material sciences, and nanotechnology and bioengineering fields.
The increasing prevalence of neurological disorders and rising incidents of nervous injuries, especially in the geriatric population, represent the key factors contributing to the global NRaR market growth. In line with this, extensive research and development (R&D) activities in the field of neurology to introduce advanced NRaR products are further catalyzing market growth. Moreover, rising healthcare expenditure and the widespread adoption of effective management and treatment strategies, such as endogenous and exogenous stem cell transplantation, are positively influencing the market growth.
Request for a free sample copy of this report: https://www.imarcgroup.com/nerve-repair-regeneration-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- Alafair Biosciences Inc.
- AxoGen Inc.
- Baxter International Inc.
- Boston Scientific Corporation
- Collagen Matrix Inc.
- Integra Lifesciences Corporation
- Medtronic plc
- Polyganics BV
- Soterix Medical Inc.
- Stryker Corporation
- Synapse Biomedical Inc.
Explore full report with table of contents: https://www.imarcgroup.com/nerve-repair-regeneration-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Surgery:
- Direct Nerve Repair/Neurorrhaphy
- Nerve Grafting
- Stem Cell Therapy
- Neurostimulation and Neuromodulation Surgeries
Breakup by Product:
- Neurostimulation and Neuromodulation Devices
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800